CN Patent

CN103237547B — 结晶纳络醇-peg缀合物

Assigned to AstraZeneca AB · Expires 2015-10-07 · 11y expired

What this patent protects

提供呈草酸盐或磷酸盐形式的下式的纳络醇-聚乙二醇缀合物，包括结晶形式。还提供了制备盐形式的方法和包含所述盐形式的药物组合物。

USPTO Abstract

提供呈草酸盐或磷酸盐形式的下式的纳络醇-聚乙二醇缀合物，包括结晶形式。还提供了制备盐形式的方法和包含所述盐形式的药物组合物。

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: CN103237547B
Jurisdiction: CN
Classification: —
Expires: 2015-10-07
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.